GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure (Q34336097)

1 August 2017

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure (English)

1 reference

atrial natriuretic peptide

1 August 2017

0 references

8

Daniel J Drucker

1 reference

1 August 2017

Minsuk Kim

1

1 reference

1 August 2017

Mathew J Platt

2

1 reference

1 August 2017

Tadao Shibasaki

3

1 reference

1 August 2017

Susan E Quaggin

4

1 reference

1 August 2017

Peter H Backx

5

1 reference

1 August 2017

Susumu Seino

6

1 reference

1 August 2017

Jeremy A Simpson

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

31 March 2013

1 reference

1 August 2017

1 reference

1 August 2017

19

1 reference

1 August 2017

567-575

1 reference

1 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.3128

1 August 2017

0 references

cites work

Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies

1 reference

The effect of glucagon-like peptide 1 on cardiovascular risk

21 January 2018

1 reference

Ongoing clinical trials evaluating the cardiovascular safety and efficacy of therapeutic approaches to diabetes mellitus

21 January 2018

1 reference

Cardiovascular biology of the incretin system

21 January 2018

1 reference

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.

21 January 2018

1 reference

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

21 January 2018

1 reference

Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism

21 January 2018

1 reference

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.

21 January 2018

1 reference

Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model

21 January 2018

1 reference

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

21 January 2018

1 reference

Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.

21 January 2018

1 reference

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

21 January 2018

1 reference

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

21 January 2018

1 reference

Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure

21 January 2018

1 reference

Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle

21 January 2018

1 reference

Identification of potential pharmacological targets by analysis of the comprehensive G protein-coupled receptor repertoire in the four cardiac chambers.

21 January 2018

1 reference

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

21 January 2018

1 reference

cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells

21 January 2018

1 reference

Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP.

21 January 2018

1 reference

Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells

21 January 2018

1 reference

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

21 January 2018

1 reference

Role of phospholipase Cε in physiological phosphoinositide signaling networks

21 January 2018

1 reference

Atrial natriuretic peptide in type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function.

21 January 2018

1 reference

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice

21 January 2018

1 reference

Genetic basis of blood pressure and hypertension

21 January 2018

1 reference

Atrial natriuretic peptide induces postprandial lipid oxidation in humans

21 January 2018

1 reference

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes

21 January 2018

1 reference

Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.

21 January 2018

1 reference

The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function.

21 January 2018

1 reference

Nitro-oleic acid inhibits angiotensin II-induced hypertension

21 January 2018

1 reference

Doxorubicin-induced vasomotion and [Ca(2+)](i) elevation in vascular smooth muscle cells from C57BL/6 mice

21 January 2018

1 reference

Navigating the signalling network in mouse cardiac myocytes

21 January 2018

1 reference

MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation

21 January 2018

1 reference

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

A highly sensitive radioreceptor assay for atrial natriuretic peptide in rat plasma.

21 January 2018

1 reference

12 December 2020

Assessing the cardiovascular safety of diabetes therapies

1 reference

12 December 2020

GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice

1 reference

12 December 2020

Effects of alpha-human atrial natriuretic peptide in essential hypertension

1 reference

12 December 2020

Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.

1 reference

12 December 2020

NHE3 phosphorylation at serines 552 and 605 does not directly affect NHE3 activity

1 reference

12 December 2020

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.3128

1 reference

1 August 2017

1 reference